8.9(top 2%)
impact factor
20.5K(top 1%)
papers
1.6M(top 1%)
citations
374(top 1%)
h-index
9.1(top 2%)
impact factor
22.3K
all documents
1.6M
doc citations
530(top 1%)
g-index

Top Articles

#TitleJournalYearCitations
1Triple-Negative Breast Cancer: Clinical Features and Patterns of RecurrenceClinical Cancer Research20073,807
2X-TileClinical Cancer Research20042,925
3Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response CriteriaClinical Cancer Research20092,857
4Therapeutic Nanoparticles for Drug Delivery in CancerClinical Cancer Research20082,565
5Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast CarcinomaClinical Cancer Research20042,393
6Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant DiseasesClinical Cancer Research20042,261
7Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung CancersClinical Cancer Research20132,097
8Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 TherapyClinical Cancer Research20142,050
9Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate CancerClinical Cancer Research20081,975
10Clinical Features of Metastatic Bone Disease and Risk of Skeletal MorbidityClinical Cancer Research20061,895
11Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer ImmunotherapyClinical Cancer Research20111,823
12The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer SubtypesClinical Cancer Research20071,786
13The Interleukin-8 Pathway in CancerClinical Cancer Research20081,747
14Breast Cancer Molecular Subtypes Respond Differently to Preoperative ChemotherapyClinical Cancer Research20051,618
15In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationshipClinical Cancer Research20031,474
16Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 AntibodyClinical Cancer Research20091,371
17Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical OutcomeClinical Cancer Research20081,312
18Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch SystemClinical Cancer Research20071,204
19The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational ResearchClinical Cancer Research20091,177
20CXCL12 (SDF-1)/CXCR4 Pathway in CancerClinical Cancer Research20101,159
21Phase II Trial of Curcumin in Patients with Advanced Pancreatic CancerClinical Cancer Research20081,158
22Phase I Clinical Trial of Oral CurcuminClinical Cancer Research20041,097
23The Pancreas Cancer MicroenvironmentClinical Cancer Research20121,087
24Prostate-specific membrane antigen expression in normal and malignant human tissuesClinical Cancer Research19971,056
25A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian CancerClinical Cancer Research20061,050
26Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative PhenotypeClinical Cancer Research20081,040
27Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.Clinical Cancer Research20061,025
28Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug ConjugateClinical Cancer Research20041,019
29Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non–Small Cell Lung CancerClinical Cancer Research20121,018
30Clinical Trial Substantiates the Predictive Value of O-6-Methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastoma Patients Treated with TemozolomideClinical Cancer Research20041,014
31Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular CarcinomaClinical Cancer Research20141,012
32Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant GliomaClinical Cancer Research20071,005
33Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast CancerClinical Cancer Research2015990
34EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective AnalysisClinical Cancer Research2016977
35The Double-Edged Sword of Autophagy Modulation in CancerClinical Cancer Research2009965
36Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1Clinical Cancer Research2017960
37Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall SurvivalClinical Cancer Research2006937
38Gemcitabine Selectively Eliminates Splenic Gr-1+/CD11b+ Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune ActivityClinical Cancer Research2005923
39EML4-ALKFusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung CancerClinical Cancer Research2008916
40Boron Neutron Capture Therapy of Cancer: Current Status and Future ProspectsClinical Cancer Research2005882
41Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer TherapyClinical Cancer Research2009875
42Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine TreatmentClinical Cancer Research2009872
43Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?Clinical Cancer Research2012855
44An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor ResistanceClinical Cancer Research2013848
45Circulating Tumor Cells in Patients with Breast Cancer DormancyClinical Cancer Research2004846
46Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation SeriesClinical Cancer Research2007839
47Reactive Oxygen Species: A Breath of Life or Death?: Fig. 1.Clinical Cancer Research2007837
48BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic MelanomaClinical Cancer Research2013832
49The Definition of Primary and Secondary GlioblastomaClinical Cancer Research2013819
50Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast CancerClinical Cancer Research2005819